Precision Biosciences DTIL
NASDAQ DTIL
$6.33 +0.07 (+1.12%)
At close: Oct 1, 2026 · 4:00 PM EDT

Precision Biosciences (DTIL) Share-based Compensation (2018 - 2026)

Updated

Precision Biosciences' Share-based Compensation came in at $1.84 million for fiscal Q2 2026 (quarter ended Jun 30, 2026), down 37.2% from $2.94 million a year earlier but up 19.0% from the prior quarter.

Analysis

Precision Biosciences (DTIL) Share-based Compensation (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Precision Biosciences reported Share-based Compensation of $7.82 million, down 37.6% year-over-year; for FY2025 (ended Dec 31, 2025), it came in at $10.19 million, down 19.2% from FY2024.

  • Share-based Compensation has declined in each of the last three fiscal years, with a five-year compound annual growth rate of -5.9% (FY2020 to FY2025).
  • Going back by fiscal year, Share-based Compensation was $12.6 million in FY2024 (-10.2%), $14.04 million in FY2023 (-26.9%), $19.2 million in FY2022 (+16.2%) and $16.51 million in FY2021 (+19.8%).
  • The five-year range for quarterly Share-based Compensation is $1.55 million (fiscal Q1 2026) to $5.14 million (fiscal Q2 2022).
  • Year-over-year, Share-based Compensation has declined for four consecutive quarters, with an average decline of 16.2% over the last eight quarters.
  • The fastest year-over-year change in Share-based Compensation over five years came in fiscal Q2 2022 (growth of 31.9%), and the weakest in fiscal Q1 2026 (a decline of 45.1%).
  • Business Quant data shows DTIL's Share-based Compensation at $1.55 million (Q1 2026), $2.04 million (Q4 2025) and $2.39 million (Q3 2025) in the three fiscal quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 458.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 166.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 231.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 170.20 Mn
10 Precision Biosciences 165.47 Mn -183.71 Mn - 1.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.84 Mn
Mar 31, 2026 1.55 Mn
Dec 31, 2025 2.04 Mn
Sep 30, 2025 2.39 Mn
Jun 30, 2025 2.94 Mn
Mar 31, 2025 2.82 Mn
Dec 31, 2024 3.57 Mn
Sep 30, 2024 3.20 Mn
Jun 30, 2024 2.93 Mn
Mar 31, 2024 2.91 Mn
Dec 31, 2023 2.97 Mn
Sep 30, 2023 3.11 Mn
Jun 30, 2023 3.87 Mn
Mar 31, 2023 4.09 Mn
Dec 31, 2022 4.54 Mn
Sep 30, 2022 5.13 Mn
Jun 30, 2022 5.14 Mn
Mar 31, 2022 4.39 Mn
Dec 31, 2021 4.44 Mn
Sep 30, 2021 4.55 Mn
API Access

Precision Biosciences Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=DTIL&period=max&api_key=YOUR_API_KEY